ClariTrial | Search Clinical Trials

Explore/infectious disease antibiotic antiviral

Status

Phase

Pre-filtered to show active, later-stage trials with the strongest clinical signal.

24 results for “infectious disease antibiotic antiviral” · Recruiting

Page 1 of 2

Recruiting

Randomized, Embedded, Multifactorial Adaptive Platform Trial for Community- Acquired Pneumonia

Phase 3Community-acquired Pneumonia, Influenza, COVID-19

CeftriaxoneMoxifloxacin or LevofloxacinPiperacillin-tazobactam+59 more

UMC Utrecht20,000 participants408 sites · United States, Australia, BelgiumCompletes Feb 2026

Compare CT.gov Full analysis →

Recruiting

Efficacy of Ustekinumab Therapy in Patients With Symptomatic Stricturing Crohn's Disease

N/ACrohn DiseaseStricture; BowelIntestinal Stricture

Ustekinumab

Second Affiliated Hospital, Zhejiang University, School of Medicine239 participants8 sites · ChinaCompletes Aug 2027

Compare CT.gov Full analysis →

Recruiting

A Study to Learn About a Study Medicine Called Ibuzatrelvir in Adult and Adolescent Patients With COVID-19 Who Are Not Hospitalized But Are at Risk For Severe Disease

Phase 3COVID-19 SARS-CoV-2 Infection

ibuzatrelvirplacebo

Pfizer2,330 participants252 sites · United States, Argentina, BelgiumCompletes Oct 2027

Compare CT.gov Full analysis →

Recruiting

CRP and Patient Information Leaflets to Optimise Antibiotic Treatments for Adults With Respiratory Tract Infections in Primary Care in Kyrgyzstan

N/ARespiratory Tract Infection BacterialRespiratory Tract Infection ViralAMR

The C-reactive protein point-of-care test (CRP-POCT)Patient information leaflets

Rigshospitalet, Denmark1,050 participants2 sites · KyrgyzstanCompletes Mar 2026

Compare CT.gov Full analysis →

Recruiting

Efficacy of QBKPN Site-Specific Immunomodulator in Improving Innate Immune Function & Reducing Respiratory Tract Infection in Older Adults

Phase 2Immune Deficiency

QBKPN SSINormal Saline Placebo

Qu Biologics Inc.72 participants1 site · CanadaCompletes Sep 2025

Compare CT.gov Full analysis →

Recruiting

Susceptibility to Infectious Diseases in obEsity: an endocRine trAnslational socioLogic Evaluation, "SIDERALE"

N/AObesityType2diabetesLipodystrophy

Mediterranean dietMelatonin supplementation

Federico II University100 participants4 sites · ItalyCompletes Oct 2025

Compare CT.gov Full analysis →

Recruiting

Impact of a Multiplex Respiratory PCR Test on Outcomes for Patients Presenting With Respiratory Illness in the Urgent Care Setting: A Hybrid-Effectiveness Quasi-Experimental Trial

N/AAcute Respiratory Infections (ARIs)

SPOTFIRE R/ST Diagnostic Test

BioMérieux800 participants2 sites · United StatesCompletes Apr 2026

Compare CT.gov Full analysis →

Recruiting

A Clinical Trial to Evaluate Efficacy, Safety, and Pharmacokinetics of Gamunex in Participants With Chronic Lymphocytic Leukemia, Multiple Myeloma, or Non-Hodgkin Lymphoma

Phase 3Chronic Lymphocytic Leukemia, Multiple Myeloma, or Non-Hodgkin Lymphoma

Gamunex-C, 10% Injectable Solution

Grifols Biologicals, LLC49 participants5 sites · United StatesCompletes Aug 2028

Compare CT.gov Full analysis →

Recruiting

CMV CTLs in Neonates With CMV Infection

Phase 2Congenital Cytomegaloviral (CMV) Disease

CMV Cytotoxic T-LymphocytesAnti-viral Therapy

New York Medical College23 participants4 sites · United StatesCompletes Oct 2027

Compare CT.gov Full analysis →

Recruiting

Modulation of Periapical Inflammation Following Nano-sized Intracanal Medication. A Randomized Controlled Clinical Trial

N/APost-operative PainPeriapical Inflammation

Nanochitosan pasteNano-calcium hydroxide pasteCalcium hydroxide paste

Al-Azhar University63 participants1 site · EgyptCompletes Jan 2027

Compare CT.gov Full analysis →

Recruiting

TriVerity™ for Improved Management of Emergency Department (ED) Patients With Suspected Infections

N/ASepsisInfectionsTachycardia

TriVerity Test

Inflammatix300 participants2 sites · United StatesCompletes Jan 2025

Compare CT.gov Full analysis →

Recruiting

A Trial to Treat Polyomavirus Infections (BKPyV) in Kidney and Simultaneous Kidney Pancreas Transplant Recipients

Phase 3BK ViremiaKidney Transplant InfectionKidney Transplant Failure and Rejection

Immunosuppression reduction/modification + intravenous immunoglobulinImmunosuppression reduction/modification

The University of Queensland280 participants13 sites · AustraliaCompletes Aug 2027

Compare CT.gov Full analysis →

Recruiting

Low-value Care, and Variation in Practice for Children Hospitalized With Bronchiolitis

N/ABronchiolitis

Provision of any of six different low-value health services for treatment of bronchiolitis

St. Justine's Hospital3,000 participants15 sites · CanadaCompletes May 2026

Compare CT.gov Full analysis →

Recruiting

A Phase 2 Trial Comparing Antiviral Treatments in Early Symptomatic Influenza

Phase 2InfluenzaInfluenza, Human

OseltamivirFavipiravirZanamivir+7 more

University of Oxford3,000 participants4 sites · Brazil, Laos, NepalCompletes Jan 2027

Compare CT.gov Full analysis →

Recruiting

Assessing Antiviral Treatments in Early Symptomatic RSV

Phase 2Respiratory Syncytial VirusRespiratory Syncytial Virus, Human

RibavirinMolnupiravirFavipiravir

University of Oxford1,000 participants2 sites · Laos, ThailandCompletes Jan 2027

Compare CT.gov Full analysis →

1–15 of 24

Explore/infectious disease antibiotic antiviral

Status

Phase

Pre-filtered to show active, later-stage trials with the strongest clinical signal.

24 results for “infectious disease antibiotic antiviral” · Recruiting

Page 1 of 2

Recruiting

Randomized, Embedded, Multifactorial Adaptive Platform Trial for Community- Acquired Pneumonia

Phase 3Community-acquired Pneumonia, Influenza, COVID-19

CeftriaxoneMoxifloxacin or LevofloxacinPiperacillin-tazobactam+59 more

UMC Utrecht20,000 participants408 sites · United States, Australia, BelgiumCompletes Feb 2026

Compare CT.gov Full analysis →

Recruiting

Efficacy of Ustekinumab Therapy in Patients With Symptomatic Stricturing Crohn's Disease

N/ACrohn DiseaseStricture; BowelIntestinal Stricture

Ustekinumab

Second Affiliated Hospital, Zhejiang University, School of Medicine239 participants8 sites · ChinaCompletes Aug 2027

Compare CT.gov Full analysis →

Recruiting

A Study to Learn About a Study Medicine Called Ibuzatrelvir in Adult and Adolescent Patients With COVID-19 Who Are Not Hospitalized But Are at Risk For Severe Disease

Phase 3COVID-19 SARS-CoV-2 Infection

ibuzatrelvirplacebo

Pfizer2,330 participants252 sites · United States, Argentina, BelgiumCompletes Oct 2027

Compare CT.gov Full analysis →

Recruiting

CRP and Patient Information Leaflets to Optimise Antibiotic Treatments for Adults With Respiratory Tract Infections in Primary Care in Kyrgyzstan

N/ARespiratory Tract Infection BacterialRespiratory Tract Infection ViralAMR

The C-reactive protein point-of-care test (CRP-POCT)Patient information leaflets

Rigshospitalet, Denmark1,050 participants2 sites · KyrgyzstanCompletes Mar 2026

Compare CT.gov Full analysis →

Recruiting

Efficacy of QBKPN Site-Specific Immunomodulator in Improving Innate Immune Function & Reducing Respiratory Tract Infection in Older Adults

Phase 2Immune Deficiency

QBKPN SSINormal Saline Placebo

Qu Biologics Inc.72 participants1 site · CanadaCompletes Sep 2025

Compare CT.gov Full analysis →

Recruiting

Susceptibility to Infectious Diseases in obEsity: an endocRine trAnslational socioLogic Evaluation, "SIDERALE"

N/AObesityType2diabetesLipodystrophy

Mediterranean dietMelatonin supplementation

Federico II University100 participants4 sites · ItalyCompletes Oct 2025

Compare CT.gov Full analysis →

Recruiting

Impact of a Multiplex Respiratory PCR Test on Outcomes for Patients Presenting With Respiratory Illness in the Urgent Care Setting: A Hybrid-Effectiveness Quasi-Experimental Trial

N/AAcute Respiratory Infections (ARIs)

SPOTFIRE R/ST Diagnostic Test

BioMérieux800 participants2 sites · United StatesCompletes Apr 2026

Compare CT.gov Full analysis →

Recruiting

A Clinical Trial to Evaluate Efficacy, Safety, and Pharmacokinetics of Gamunex in Participants With Chronic Lymphocytic Leukemia, Multiple Myeloma, or Non-Hodgkin Lymphoma

Phase 3Chronic Lymphocytic Leukemia, Multiple Myeloma, or Non-Hodgkin Lymphoma

Gamunex-C, 10% Injectable Solution

Grifols Biologicals, LLC49 participants5 sites · United StatesCompletes Aug 2028

Compare CT.gov Full analysis →

Recruiting

CMV CTLs in Neonates With CMV Infection

Phase 2Congenital Cytomegaloviral (CMV) Disease

CMV Cytotoxic T-LymphocytesAnti-viral Therapy

New York Medical College23 participants4 sites · United StatesCompletes Oct 2027

Compare CT.gov Full analysis →

Recruiting

Modulation of Periapical Inflammation Following Nano-sized Intracanal Medication. A Randomized Controlled Clinical Trial

N/APost-operative PainPeriapical Inflammation

Nanochitosan pasteNano-calcium hydroxide pasteCalcium hydroxide paste

Al-Azhar University63 participants1 site · EgyptCompletes Jan 2027

Compare CT.gov Full analysis →

Recruiting

TriVerity™ for Improved Management of Emergency Department (ED) Patients With Suspected Infections

N/ASepsisInfectionsTachycardia

TriVerity Test

Inflammatix300 participants2 sites · United StatesCompletes Jan 2025

Compare CT.gov Full analysis →

Recruiting

A Trial to Treat Polyomavirus Infections (BKPyV) in Kidney and Simultaneous Kidney Pancreas Transplant Recipients

Phase 3BK ViremiaKidney Transplant InfectionKidney Transplant Failure and Rejection

Immunosuppression reduction/modification + intravenous immunoglobulinImmunosuppression reduction/modification

The University of Queensland280 participants13 sites · AustraliaCompletes Aug 2027

Compare CT.gov Full analysis →

Recruiting

Low-value Care, and Variation in Practice for Children Hospitalized With Bronchiolitis

N/ABronchiolitis

Provision of any of six different low-value health services for treatment of bronchiolitis

St. Justine's Hospital3,000 participants15 sites · CanadaCompletes May 2026

Compare CT.gov Full analysis →

Recruiting

A Phase 2 Trial Comparing Antiviral Treatments in Early Symptomatic Influenza

Phase 2InfluenzaInfluenza, Human

OseltamivirFavipiravirZanamivir+7 more

University of Oxford3,000 participants4 sites · Brazil, Laos, NepalCompletes Jan 2027

Compare CT.gov Full analysis →

Recruiting

Assessing Antiviral Treatments in Early Symptomatic RSV

Phase 2Respiratory Syncytial VirusRespiratory Syncytial Virus, Human

RibavirinMolnupiravirFavipiravir

University of Oxford1,000 participants2 sites · Laos, ThailandCompletes Jan 2027

Compare CT.gov Full analysis →

1–15 of 24